Savara Inc.
SVRA•NASDAQ•Healthcare•Biotechnology

About Savara

Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases. The company’s lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase 3 development stage for the treatment of autoimmune pulmonary alveolar proteinosis. The company was founded in 2007 and is headquartered in Langhorne, Pennsylvania.

Company Information

SectorHealthcare
IndustryBiotechnology
CEOMatthew Pauls
Founded2007
Employees59
CountryUnited States
Fiscal YearJanuary - December

Stock Details

ExchangeNASDAQ (NASDAQ)
CurrencyUSD - USD
TypeStock
SubtypeCommon Stock

Contact Information

Websitewww.savarapharma.com
Phone512 614 1848
Address
1717 Langhorne Newtown Road, Suite 300 Langhorne, Pennsylvania 19047 United States

Corporate Identifiers

CIK0001160308
CUSIP805111101
ISINUS8051111016
EIN84-1318182
SIC2834

Leadership Team & Key Executives

Matthew Pauls J.D., M.B.A.
Chairman and Chief Executive Officer
David L. Lowrance CPA
Chief Financial Officer, Chief Administrative Officer and Secretary
Robert Matthew Lutz M.B.A.
Chief Operating Officer
Kate McCabe J.D.
Chief Legal Officer
Anne Erickson
Chief Business Officer
Brian Maurer
Head of Clinical Operations
Charles LaPree
Executive Vice President and Head of Global Regulatory Affairs
Dr. Brian Robinson M.D.
Executive Vice President of Global Medical Affairs
Dr. Yasmine Wasfi M.D., Ph.D.
Chief Medical Officer
Dr. Siddharth J. Advant Ph.D.
Executive Vice President of Global Technical Operations